CLL

Conference Coverage

Why CLL may go chemo free

NEW YORK – The approach to treating chronic lymphocytic leukemia is evolving, and while chemoimmunotherapy remains a reasonable initial option in...

MD IQ

Conference Coverage

Ibrutinib continues to wow in CLL/SLL

SAN DIEGO – More than 90% of the first patients with previously untreated chronic lymphocytic leukemia who received ibrutinib in an early study...

Pages